Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Pancreatic Neoplasms × Observation × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 7 Leukemia, Myeloid, Acute 4 Neoplasm Metastasis 3 Lung Neoplasms 3 Endometrial Neoplasms 3 Colonic Neoplasms 3 Breast Neoplasms 3 Sarcoma 2 Oropharyngeal Neoplasms 2 Neuroblastoma 2 Melanoma 2 Leukemia, Myelomonocytic, Acute 2 Leukemia, Monocytic, Acute 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Erythroblastic, Acute 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Anus Neoplasms 2 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Squamous Intraepithelial Lesions 1 Smoldering Multiple Myeloma 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Pleuropulmonary blastoma 1 Pathologic Complete Response 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1

Interventions

Gemcitabine 63 Fluorouracil 28 Leucovorin 18 Oxaliplatin 17 130-nm albumin-bound paclitaxel 12 Capecitabine 11 Irinotecan 9 Albumin-Bound Paclitaxel 9 irinotecan sucrosofate 6 Radiotherapy 6 folfirinox 4 Taxes 4 Erlotinib Hydrochloride 4 rubitecan 3 Surgical Procedures, Operative 3 Specimen Handling 3 Pancreaticojejunostomy 3 Neoadjuvant Therapy 3 Drug Therapy 3 Cisplatin 3 ruxolitinib 2 masitinib 2 dehydroftorafur 2 Saline Solution 2 Paclitaxel 2 Fentanyl 2 Chemotherapy, Adjuvant 2 Bevacizumab 2 Acupuncture Therapy 2 viscum album peptide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06958328 2026-02-02

LAP100

NRG Oncology

Phase 3 Recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡